READY

IMCAS 2024: Galderma to Present Latest Updates From Its Unparalleled Aesthetics Portfolio Reinforcing Its Leadership Position

Retrieved on: 
Thursday, January 25, 2024

Galderma will be sharing the latest updates from across its broad and unparalleled portfolio at the International Master Course on Aging Science (IMCAS) World Congress 2024 from February 1-3, 2024, in Paris.

Key Points: 
  • Galderma will be sharing the latest updates from across its broad and unparalleled portfolio at the International Master Course on Aging Science (IMCAS) World Congress 2024 from February 1-3, 2024, in Paris.
  • The updates reinforce Galderma’s leadership in aesthetic injectables and dermatological skincare.
  • “The breadth of our data and activities at IMCAS truly embodies our commitment to responding directly to the needs of healthcare professionals and patients.
  • Three symposia will highlight Galderma’s innovations and science as well as educational efforts to support the aesthetics community.

Multiple New Analyses Reinforce the Role of BAVENCIO® (avelumab) First-Line Maintenance as a Standard of Care in Patients with Locally Advanced or Metastatic Urothelial Carcinoma

Retrieved on: 
Monday, January 22, 2024

Data include real-world studies that confirm median overall survival (OS) of approximately 30 months in patients without progression after first-line chemotherapy.

Key Points: 
  • Data include real-world studies that confirm median overall survival (OS) of approximately 30 months in patients without progression after first-line chemotherapy.
  • These and other analyses will be presented at the 2024 American Society of Clinical Oncology’s annual Genitourinary Cancers Symposium, January 25-27, in San Francisco.
  • “Avelumab in the first-line maintenance setting is a standard of care for patients with locally advanced or metastatic bladder cancer, with a well-established efficacy and safety profile and supported by years of real-world experience.
  • READY CUP Italy Real-World Study: The prospective, noninterventional compassionate use program (CUP) provided Italian patients with locally advanced or metastatic UC early access to BAVENCIO first-line maintenance before reimbursement.

Multiple New Analyses Reinforce the Role of BAVENCIO® (avelumab) First-Line Maintenance as a Standard of Care in Patients with Locally Advanced or Metastatic Urothelial Carcinoma

Retrieved on: 
Monday, January 22, 2024

Data include real-world studies that confirm median overall survival (OS) of approximately 30 months in patients without progression after first-line chemotherapy.

Key Points: 
  • Data include real-world studies that confirm median overall survival (OS) of approximately 30 months in patients without progression after first-line chemotherapy.
  • These and other analyses will be presented at the 2024 American Society of Clinical Oncology’s annual Genitourinary Cancers Symposium, January 25-27, in San Francisco.
  • “Avelumab in the first-line maintenance setting is a standard of care for patients with locally advanced or metastatic bladder cancer, with a well-established efficacy and safety profile and supported by years of real-world experience.
  • READY CUP Italy Real-World Study: The prospective, noninterventional compassionate use program (CUP) provided Italian patients with locally advanced or metastatic UC early access to BAVENCIO first-line maintenance before reimbursement.

Toyota Motor Corporation Collaborates with READY Robotics to Introduce Sim-to-Real Robotic Programming in Industrial Manufacturing Using NVIDIA Omniverse

Retrieved on: 
Wednesday, January 17, 2024

Toyota will employ READY ForgeOS in tandem with NVIDIA Isaac Sim , a robotics simulator developed on NVIDIA Omniverse , to build a state-of-the-art simulated robotic programming environment for its aluminum hot forging production lines.

Key Points: 
  • Toyota will employ READY ForgeOS in tandem with NVIDIA Isaac Sim , a robotics simulator developed on NVIDIA Omniverse , to build a state-of-the-art simulated robotic programming environment for its aluminum hot forging production lines.
  • Typically, programming robotic systems for forging necessitates that the metal parts remain hot during programming, presenting significant safety challenges.
  • ForgeOS simplifies the programming process, reducing the typical complexities of robotic systems and enabling an easy-to-use experience for any industrial robotic manipulator.
  • "The collaboration between Toyota and READY Robotics is a great example of the pioneering use of technology, such as NVIDIA Isaac Sim, to unlock industrial digitalization possibilities in manufacturing."

TOXINS 2024: Galderma’s Phase III RelabotulinumtoxinA Results Demonstrate Positive Efficacy and Long Duration of Effect When Treating Frown Lines and Crow’s Feet Simultaneously

Retrieved on: 
Wednesday, January 17, 2024

Galderma announced today positive topline results from the phase III READY-3 clinical trial investigating the use of RelabotulinumtoxinA for the treatment of glabellar lines (frown lines) and lateral canthal lines (crow’s feet), either alone (single-area) or simultaneously.

Key Points: 
  • Galderma announced today positive topline results from the phase III READY-3 clinical trial investigating the use of RelabotulinumtoxinA for the treatment of glabellar lines (frown lines) and lateral canthal lines (crow’s feet), either alone (single-area) or simultaneously.
  • “We’re looking forward to sharing the latest updates from our world-leading injectable aesthetics portfolio at TOXINS 2024, particularly first data from our phase III READY-3 trial.
  • READY-3 is a phase III randomized, double-blind, placebo-controlled trial designed to assess the safety and efficacy, as measured by aesthetic improvement, of RelabotulinumtoxinA in patients with moderate to severe frown lines or crow’s feet, either administered as a single-area treatment or simultaneously on both frown lines and crow’s feet, when compared to placebo.
  • Results showed rapid onset of action, with over a third of patients seeing results on day 1 for frown lines (39%) and crow’s feet (34%), and demonstrated long duration of effect for six months.

KATE UPTON JOINS VOSA SPIRITS AS CO-OWNER

Retrieved on: 
Wednesday, October 25, 2023

DETROIT, Oct. 25, 2023 /PRNewswire/ -- Vosa Spirits, an innovator in the canned Ready To Drink space, is proud to announce that supermodel, actress, and entrepreneur Kate Upton has joined the company as a Co-Owner. After trying Vosa herself and learning about the brand ethos, Kate was impressed by Vosa's commitment to pushing boundaries, setting new standards, and delivering exceptional quality. Drawn to Vosa's commitment to redefining the canned cocktail landscape, Kate's decision to join the brand was an easy one. 

Key Points: 
  • "I love sharing a drink with friends and family, making sure I'm drinking something that's free of preservatives and made with high-quality spirits is important to me," says Kate Upton, Co-Owner, Vosa Spirits.
  • "We admire Kate greatly, and we were delighted to learn that she loved our cocktail offerings," shared Spencer Bailey, Co-Founder & CEO, Vosa Spirits.
  • Kate joins as Vosa introduces two new product lines: Vodka Water (SRP $10.99 / 4-pack) and High Line (SRP $12.99 / 4-pack).
  • Both The Vodka Water and The High Line represent Vosa Spirits' unwavering dedication to using premium ingredients and exceptional craftsmanship.

THE CENTER FOR DISCOVERY CEO PATRICK H. DOLLARD TO MOVE INTO SENIOR ADVISORY ROLE IN THE NEW YEAR

Retrieved on: 
Monday, October 16, 2023

HARRIS, N.Y., Oct. 16, 2023 /PRNewswire/ -- THE CENTER FOR DISCOVERY® (TCFD) TODAY ANNOUNCED THAT CHIEF EXECUTIVE OFFICER PATRICK H. DOLLARD, WHO HAS LED THE ORGANIZATION FOR 43 YEARS, HAS DECIDED TO TRANSITION INTO A NEW ROLE AS SENIOR ADVISOR. THE BOARD OF DIRECTORS IMMEDIATELY NAMED DR. THERESA HAMLIN, ITS PRESIDENT, TO SUCCEED HIM. THE CHANGES ARE EFFECTIVE AT THE START OF THE NEW YEAR. 

Key Points: 
  • I HAVE REALLY ENJOYED WORKING CLOSELY WITH HIM OVER THIS PAST DECADE AND THE BOARD IS DELIGHTED HE WILL CONTINUE TO SERVE AS A SENIOR ADVISOR.
  • AS PATRICK TRANSITIONS INTO A SENIOR ADVISORY ROLE, WE ARE FORTUNATE TO HAVE DR. THERESA HAMLIN ASSUME THE CEO POSITION AT THE START OF THE NEW YEAR."
  • "TODAY TCFD IS RECOGNIZED AS A NATIONAL CENTER OF EXCELLENCE THANKS TO PATRICK'S ADVOCACY AND THOUGHT LEADERSHIP OVER FOUR DECADES.
  • "WE ARE GRATEFUL TO PATRICK FOR HIS BOLD VISION AND LEADERSHIP, AND FORTUNATE TO HAVE SOMEONE AS QUALIFIED, ENTHUSIASTIC AND READY FOR THE FUTURE AS TERRY."

Affinity Empowering Launches READY™, Platform Technology to Improve Access to Care

Retrieved on: 
Thursday, June 22, 2023

READY is a self-guided mental and physical health and wellness management program that offers poly-chronic disease management and wellness solutions for patients, providers, and health care systems.

Key Points: 
  • READY is a self-guided mental and physical health and wellness management program that offers poly-chronic disease management and wellness solutions for patients, providers, and health care systems.
  • READY provides scalable technology to assess and support mental health and wellness conditions and presents personalized user content, packaged into an intuitive and engaging user platform.
  • READY offers self-guided pathways addressing mental and physical health conditions with content designed by clinicians to ensure users get top-quality support.
  • "We are proud to unveil READY, our highly customizable digital engagement tool that better integrates care into daily life," said Dr. Michael Tkach, Chief Operating Officer of Affinity Empowering.

READY Robotics and the Industrial Solutions Network of CED Partner to Empower Industrial Customers with ForgeOS

Retrieved on: 
Monday, June 19, 2023

COLUMBUS, Ohio, June 19, 2023 /PRNewswire/ -- READY Robotics, a pioneer in innovative automation solutions and Rockwell Automation Technology Partner, announced a strategic partnership with the Industrial Solutions Network (ISN) locations of CED, a leading industrial automation solutions company.

Key Points: 
  • COLUMBUS, Ohio, June 19, 2023 /PRNewswire/ -- READY Robotics, a pioneer in innovative automation solutions and Rockwell Automation Technology Partner, announced a strategic partnership with the Industrial Solutions Network (ISN) locations of CED, a leading industrial automation solutions company.
  • "We are excited to partner with the Industrial Solutions Network of CED to expand the reach of ForgeOS within the industrial landscape," said Benjamin Gibbs, CEO of READY Robotics.
  • "As a leader in the manufacturing industry, the Industrial Solutions Network of CED is committed to offering innovative solutions that enable our customers to thrive in a rapidly evolving marketplace," said Brandon Bernier, Partner Ecosystem Business Lead at Industrial Solutions Network.
  • The partnership between READY Robotics and the Industrial Solutions Network of CED represents a significant milestone in the automation industry, combining cutting-edge technology with Rockwell Automation's extensive distribution network, paving the way for the widespread adoption of advanced robotics solutions.

Hyundai Motor Group Supports Busan's Bid to Host World Expo 2030 with Fleet of 'Busan' Branded EVs in Paris

Retrieved on: 
Monday, June 19, 2023

Hyundai Motor Group to support Busan's bid to host the World Expo 2030 during the 172nd General Assembly of Bureau International des Expositions (BIE) in Paris, from June 20 to 21

Key Points: 
  • Hyundai Motor Group to support Busan's bid to host the World Expo 2030 during the 172nd General Assembly of Bureau International des Expositions (BIE) in Paris, from June 20 to 21
    The Group to provide fleet of 10 dedicated-EV models wrapped in 'BUSAN is READY!'
  • The Group will be providing ten EVs, wrapped with the Busan logo, as transportation to the Korean delegation.
  • This initiative will promote Busan as a candidate for hosting the World Expo, to major figures from the BIE member countries as well as tourists from all over the world who are visiting Paris.
  • During the 170-171st BIE General Assembly in June and November 2022, the Group demonstrated vehicles wrapped with the Busan World Expo logo at major tourist attractions in Paris.